Form D · Other

Biorem Inc.

Guelph, A6 · CIK 0001549823

Offering snapshot reported Aug 14, 2012 · SEC filing

Reported sold: $980K
Investors reported: 1
Minimum accepted: $0
First sale: Jul 24, 2012

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 14, 2012	Initial	$979,624	No comparison	1	SEC filing
May 11, 2012	Initial	$301,326	No comparison	1	SEC filing

Offering details

Securities: Equity, Debt, Option to acquire, Security to be acquired, Other
Exemptions: 06
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-182685

The additional $546,576 may be received upon exercise of share purchase warrants sold inside and outside the U.S. U.S dollar amounts are based on the Bank of Canada noon rate of exchnage reported on July 24, 2012, which was Cdn$1.0208=US$1.00.

A unit is comprised of a $1,000 principal amount convertible debenture and 4,545 share purchase warrants. A warrant is exercisable for 1 common share at an exercise price of Cdn$0.11 per share, for a period of 2 years.

Source: Form D, filed Aug 14, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Doug Alexander	Director
Stephen V. Ardia	Director
Peter A. Bruijns	Director, Executive
Hadi Husain	Executive
Bernardo H. Llovera	Director
Robert B. Nally	Director
Douglas Newman	Executive
H.J. Vander Laan	Director
Derek S. Webb	Executive

Issuer details

Industry: Other (See others in industry)

Address:

7496 Wellington Road 34, R.R. #3
Guelph, A6, N1H 6H9